Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126011651 | 12601165 | 1 | I | 20160726 | 20160728 | 20160728 | EXP | FR-ROCHE-1803272 | ROCHE | 45.00 | YR | M | Y | 0.00000 | 20160728 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126011651 | 12601165 | 1 | PS | VALIUM | DIAZEPAM | 1 | Oral | U | 13263 | TABLET | |||||||||
126011651 | 12601165 | 2 | SS | BUPRENORPHINE. | BUPRENORPHINE | 1 | Respiratory (inhalation) | U | 0 | 4 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126011651 | 12601165 | 1 | Product used for unknown indication |
126011651 | 12601165 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126011651 | 12601165 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126011651 | 12601165 | Drug dependence | |
126011651 | 12601165 | Emphysema |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126011651 | 12601165 | 1 | 2013 | 0 | ||
126011651 | 12601165 | 2 | 1997 | 0 |